Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge

NCT01919489 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01919489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01919489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge
Lead sponsor
Emory University
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
August 30, 2020
Enrollment
273 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes